Medicare’s Cancer Drug Payments Meet Most Oncologists’ Costs, OIG Says
Executive Summary
An HHS Office of Inspector General report says most oncology practices receive adequate reimbursement from Medicare for the drugs they use, but the American Society of Clinical Oncology is disputing the relevance of the findings, saying they are based on outdated data